ROIVANT SCIENCES GMBH has a total of 21 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are NEOTHERAPEUTICS INC, CALITOR SCIENCES LLC and UNIVABLOT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Taiwan | 2 | |
#4 | Argentina | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hungary | 1 | |
#10 | Serbia | 1 | |
#11 | Singapore | 1 | |
#12 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Goldberg Daniel R | 13 |
#2 | Scribner Andrew | 10 |
#3 | Sjogren Eric Brian | 10 |
#4 | Brameld Kenneth | 10 |
#5 | De Lombaert Stéphane | 8 |
#6 | De Lombaert Stephane | 7 |
#7 | Patterson Daniel | 2 |
#8 | Paralkar Vishwas | 2 |
#9 | Aiello Robert J | 2 |
#10 | Goldberg Deniel R | 1 |
Publication | Filing date | Title |
---|---|---|
US2020148681A1 | Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing | |
WO2019106571A1 | Dosing regimens for the treatment of fungal infections | |
CN110177790A | The fractionation of optical activity diaza spiro [4.5] decane derivative | |
TW201818964A | Methods of using tryptophan hydroxylase inhibitors |